Treatment of Deep Vein Thrombosis. A Trial of Heparin, Streptokinase, and Arvin

Thirty patients with deep vein thrombosis of the legs of less than four days' duration were allocated at random to treatment with heparin, streptokinase, or Arvin under laboratory control. When the fate of the thrombi was assessed by objective techniques-phlebography and the (125)I-labelled fibrinog... View More